|
1 |
11 05 2026 |
Manufacturers await NPPA intervention as production of cancer drugs become unviable due to platinum price surge |
Pharmabiz |
India |
|
2 |
11 05 2026 |
Biocon Pharma receives Health Canada approval for micafungin for injection USP 50 mg and 100 mg |
Business Standard |
India |
|
3 |
11 05 2026 |
Panel asks Ministry of Ayush to identify priority partner countries for promotion of traditional medicines |
Pharmabiz |
India |
|
4 |
11 05 2026 |
BDCDA concerned over growing threat of drug misuse and antimicrobial resistance |
Pharmabiz |
India |
|
5 |
11 05 2026 |
Novartis seeks to deepen India innovation play |
Health world (Economic Times) |
India |
|
6 |
11 05 2026 |
White House considering naming FDA food chief as acting commissioner-sources |
Health world (Economic Times) |
USA |
|
7 |
10 05 2026 |
India's Drug panel recommends Wegovy for Metabolic liver disease treatment |
Medical Dialogues |
India |
|
8 |
10 05 2026 |
GSK moves closer to India Launch of RSV vaccine |
Medical Dialogues |
India |
|
9 |
10 05 2026 |
Government releases updated list of approved COVID-19 vaccine in India |
Medical Dialogues |
India |
|
10 |
10 05 2026 |
Aurobindo arm CuraTeQ clears key CDSCO hurdle for Bevacizumab cancer biosimilar |
Medical Dialogues |
India |
|
11 |
10 05 2026 |
Chinese medicines bring relief to India’s cancer patients |
Health world (Economic Times) |
India |
|
12 |
10 05 2026 |
Pharma Companies Invest In US While India Still Depends On China For APIs |
Deccan Chronicle |
India |
|
13 |
10 05 2026 |
Drugmakers must report safety data from launch date, not approval date: CDSCO |
Economic Times |
India |
|
14 |
10 05 2026 |
USTR Special 301 report: Incentivising formulations will shield the sector, says pharma exporters |
New Indian Express |
India |
|
15 |
09 05 2026 |
Reply within 30 days or Sugam applications will be rejected ,CDSCO warns applicants |
Medical Dialogues |
India |
|
16 |
09 05 2026 |
Torrent emerges early leader in India's generic Semaglutide race with 38% market share:Report |
Medical Dialogues |
India |
|
17 |
09 05 2026 |
Trump signs off on plan to remove USFDA commissioner Marty Makary:Report |
Medical Dialogues |
India |
|
18 |
09 05 2026 |
Indian pharma moving from volume-led generics to value plus innovation-led growth through strategic M&As |
Pharmabiz |
India |
|
19 |
09 05 2026 |
Parliamentary Panel asks Ministry of Ayush to create dedicated Ayush Infra Fund |
Pharmabiz |
India |
|
20 |
09 05 2026 |
Drug regulator cracks down on delayed safety reporting by pharma companies |
Health world (Economic Times) |
India |
